The cheapest tirzepatide, sorted by what each program actually publishes

In its favor

• Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
• Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
• Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
• Free, no-obligation online assessment before you pay anything

Against it

• Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
• Promo-driven pricing with countdown timers and 'price increases' urgency; the $109 monthly rate was a summer promotion when read on August 28, 2026
• A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
• Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
• Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

In its favor

• One price at every dose, stated on the page in those words
• The figure covers the consultation, the care, the medication and the supplies
• Names four state-licensed 503A compounding pharmacies with addresses and phone numbers
• Publishes a phone number, and states 50-state availability in the Terms rather than only in marketing copy

Against it

• The homepage's "Starting at $49 /mo" is the twelve-month semaglutide rung; the month-to-month semaglutide rate is $79
• A "No auto rebill" chip sits against Terms that charge automatically at recurring intervals until you cancel
• A countdown clock warning that the price increases runs on every offer page with no dated deadline behind it
• The order becomes non-refundable the moment the medical intake is submitted
• The refund page signs both "Leanmeds, Inc." and "Leanmeds LLC", and the Terms say the site is operated by a third company
• No individual clinician is named and no NPI appears anywhere

In its favor

• Both the 28-day rate and the prepay rate are published, and the prepay is shown as a total as well as a per-month figure
• The intake states the cadence explicitly — shipped every 28 days, billed every 28 days
• Publishes a named legal entity and support hours
• Names the telehealth platform that stands behind the prescriptions

Against it

• The homepage's "From $75/mo" and "From $124/mo" are three-month prepay rates; the standing rates are $87 and $126
• A hero reading "Prices start from $87" sits above a grid whose lowest figure is $63
• The pharmacy that compounds the GLP-1s is not named — the one pharmacy the site does name appears only on the sermorelin, NAD+ and glutathione pages
• No clinician, medical group or NPI is named, and no 503A or 503B designation appears
• Refunds are not guaranteed, and the Terms say fees are not refundable in whole or in part
• The plan FAQ says shipping averages two days while the shipping policy says five to seven

In its favor

• Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
• Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
• LegitScript Certified
• Publishes the FDA compounded-medication disclaimer
• Covers 49 states with an explicit state list, not vague "most states" language

Against it

• No corporate legal entity disclosed — only the trade name "VitaraRx"
• No named medical director — all clinical decisions made by independent providers (marketplace model)
• All sales final — no medication returns
• Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
• Doesn't ship to Alaska

In its favor

• Tirzepatide and semaglutide cost the same, which takes price out of the choice between the two molecules
• A $179 single-month option exists for anyone who does not want an auto-refill running
• Names its dispensing pharmacy with a street address and a phone number, and names a prescribing practice
• Publishes support hours as well as an email address

Against it

• Two different medical groups are named on the same site — one on the contact page and FAQ, another in the telehealth consent
• The "free online visit" on the product pages is contradicted by Terms making the initial visit the patient's own cost
• Membership fees are non-refundable once paid, and the Terms say so in those words
• No 503A or 503B designation is given for the named pharmacy
• The FAQ says all 50 states while the Terms say certain states only, and no list is published

In its favor

• One price at every dose, stated on the product page in those words
• The figure covers the medication, the physician consultation and free expedited shipping
• Names its clinical network and that network's founder
• Oral drops and an orforglipron tablet program are priced publicly alongside the injection

Against it

• The payment obligation covers a whole 60- or 90-day protocol and opting out needs 15 days' notice, which is not the "cancel at any time" the FAQ promises
• All sales are final: consultations are non-refundable once review begins, medication once it reaches a pharmacy, and renewal charges outright
• No legal entity suffix and no street address are published — the site gives a city and a state
• The pharmacy is not named, only a 503A/503B class
• The product URL says B12 while the page itself says vitamin B6, and the pricing table still contains a placeholder row reading "Service name $20"
• No phone number and no support hours are published anywhere

In its favor

• Flat $149/month that stays the same across every dose level — no escalation surcharge as you titrate up
• Doctor-reviewed protocols filled by a 503A compounding pharmacy
• Included 1:1 support from nurses and registered dietitians
• Automatic refund if you are not approved for treatment

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — see our evidence guide
• Single-medication focus rather than a broad telehealth catalog

In its favor

• Sublingual tirzepatide lozenges at the same price as the injection, so the needle is optional without paying a premium for it
• Free physician visit, free shipping and free follow-up care included in the price
• Subscriptions can be canceled, paused or delayed yourself with 48 hours' notice
• Every route and price is published on the product page rather than hidden behind an intake

Against it

• At $199/month it costs more than CoreAge's flat $149 for the same molecule
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Asynchronous by design — in many states you will never speak to the prescriber
• Not available in Arkansas
• FDA issued the company a warning letter in February 2026 — read it on FDA's own site

In its favor

• LegitScript certified
• Unlimited telehealth visits and free shipping bundled into the monthly rate rather than billed as extras
• Both compounded semaglutide and compounded tirzepatide product lines
• The first-month price is published openly, with the compare-at rate shown alongside it

Against it

• The ongoing price after month one is not published — it could be flat at $239 or step up toward $379, and the site does not say
• Because no ongoing rate is confirmable, this entry is excluded from our price aggregates rather than assigned an assumed figure
• The legal entity name and state of incorporation are not disclosed
• The compounding pharmacy partner is not named and per-state availability is not listed
• Compounded only — no brand-name GLP-1 path

In its favor

• $159 flat 'all doses' pricing — no per-tier escalation as you titrate up, unlike competitors that start cheap then jump past $200
• No membership — pay-as-you-go monthly, cancel anytime with 48-hour notice
• Publishes the FDA compounded-medication disclaimer
• 36 states listed explicitly — strong coverage

Against it

• Easily confused with Mint Medical Clinic (a separate Utah-only med spa)
• 503A/503B pharmacy partner not named, and the compounding designation isn't specified
• Named medical director / clinical leadership not disclosed
• Corporate legal entity not disclosed
• Governing law, arbitration venue, and physical address not disclosed

In its favor

• Single all-in monthly fee with no separate membership stacked on top
• Provider visit, medication, supplies, ongoing care, and shipping included in the quoted price

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Quoted price is a starting figure that rises with higher doses and certain plans
• Compounded GLP-1 programs operate in a contracting, enforcement-heavy regulatory space post-shortage

In its favor

• Flat pricing across every dose — titrating up to a therapeutic dose does not raise the bill
• Both compounded tirzepatide and compounded semaglutide on one account
• Available in all 50 states
• A published price ladder you can read before starting an intake, which is rarer in this category than it should be

Against it

• The advertised $139 requires paying $1,668 for twelve months up front; month-to-month is $179
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• The microdose line's 'limited time' strike-through pricing has persisted long enough that it reads as regular pricing
• Very little published detail about the clinicians or the compounding pharmacy behind the prescription

In its favor

• Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
• Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
• Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
• Both compounded and branded GLP-1s offered side by side — unusual for a compounded provider
• Self-pay model with no insurance required and no separate consultation fee

Against it

• No public list of states served — you must complete intake to learn if your state qualifies
• No named 503A compounding pharmacy partner, limiting licensure verification
• No LegitScript, PCAB, or BBB trust badges visible
• Brand confusion: site schema names 'CatalystMD' while the customer-facing brand is Aquivia Health

In its favor

• Names a pharmacy partner and a medical director with stated credentials
• The 28-day cycle is stated in the billing terms rather than described as monthly and left there
• Publishes a phone number and 24/7 support hours
• A forty-product peptide catalog is priced publicly alongside the GLP-1 line

Against it

• The cost pages and the product pages disagree — $149 against $179 for tirzepatide, and $79 against $109 for semaglutide
• "All-in monthly price" sits above billing terms that charge every 28 days and can bill twice in one calendar month
• Labs are included only where the provider requires them, with a deeper panel charged separately at $149
• An "FDA CLEARED" badge sits in the homepage trust cluster while the product pages state that compounded medications are not FDA-approved or cleared
• Payment is taken before the physician reviews the intake; the refund is the remedy
• Which pharmacy fills a given order is not stated, and the one partner named carries no legal entity or address

In its favor

• A genuinely flat $179/month at every dose, month-to-month, with no membership fee, no per-visit fees and a stated pause-or-cancel-anytime policy
• No prepay ladder to navigate — the advertised rate is the rate, rather than a twelve-month rung dressed as a monthly price
• Names three physicians on its medical board — Dr. Marc Gruner (sports medicine, trained at Mayo Clinic), Dr. Jonathan Hinds (board-certified emergency medicine, trained at Rutgers) and Dr. Gregory Tennant (fellowship-trained orthopedic trauma surgeon, trained at Vanderbilt)
• Free two-day temperature-controlled shipping with injection supplies included in the price

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — the lander carries its own bolded FDA disclosure saying so
• The $99 headline is a FIRST-MONTH introductory rate; the ongoing price is $179/month
• Does not name the compounding pharmacy — only "a certified U.S. pharmacy"
• Does not publish which states it serves, so eligibility is unknowable before the intake
• Tirzepatide only — no semaglutide SKU, no brand-name pathway, and no oral or sublingual route

In its favor

• Flat pricing — same cost at every dose, no escalation as you titrate up
• All-inclusive: doctor consultation, prescription, medication, and free shipping in one price
• LegitScript-certified; prescriptions reviewed by US-licensed M.D.s
• Offers both compounded semaglutide ($149/mo) and tirzepatide ($196/mo)

Against it

• Membership fee is non-refundable once paid
• Partner pharmacy is not publicly named
• State availability not published (limited to 'certain states')

In its favor

• Entirely online with free shipping and a broad telehealth catalog
• Low promotional membership price for the first month

Against it

• Stacked cost: the membership ($99/month after the first month) is charged on top of the $199/month medication
• Membership is required to access a prescription and does not guarantee one
• Total monthly outlay can exceed CoreAge once the membership renews

In its favor

• Transparent flat monthly pricing published upfront (139 dollars semaglutide, 199 dollars tirzepatide)
• Free initial virtual consultation with a licensed provider
• Both semaglutide and tirzepatide offered with ongoing provider check-ins

Against it

• Compounding pharmacy is not named publicly
• States served are not listed on the site
• Thin public trust signals (no LegitScript seal or named medical director found)

In its favor

• Publishes a named legal entity and two physical clinic addresses
• The intake shows the plan list with three-month totals rather than only per-month equivalents
• Twenty-six telehealth states are enumerated by name rather than claimed as nationwide coverage
• Publishes a phone number and a working support address

Against it

• The advertised "Starting at $179" is a three-month prepay divided by three; a first-time patient is routed to titration plans that cost more
• A third price pair on the GLP-1 page — $109 and $159, with B-6 rather than B12 — appears nowhere else on the site
• All 127 sitemap URLs point at a domain that does not resolve, and the Terms' only cancellation address is on that same dead domain
• Louisiana is absent from the telehealth list although both clinics are in Louisiana, and no in-clinic price of any kind is published
• A strict no-refund policy, including where the company itself terminates the membership
• No compounding pharmacy, clinician or 503 designation is named

In its favor

• One price at every dose, published on the GLP-1 page before any intake
• Names its dispensing pharmacy, its designated medical group and a medical director with an NPI
• Publishes a named legal entity and an Austin, Texas address
• Publishes support hours

Against it

• The "ALL 50 STATES" banner is contradicted by the program's own FAQ, which says the program is suppressed in Connecticut, Ohio and South Carolina "at minimum", with no list
• The Terms accepted at intake are unedited platform boilerplate: they name a different professional entity 25 times and carry 14 unfilled [INSERT …] placeholders, including in the sentence telling a patient how to cancel
• Two fees the marketing site never mentions appear in those Terms — a $15.00 additional consult or lab interpretation and a $125.00 at-home blood draw
• The two Terms documents state opposite refund rules with no clause saying which governs
• What the $199 buys is itemized nowhere, and neither the three- nor the six-month plan has a published total
• No 503A or 503B designation appears anywhere on the site

In its favor

• LegitScript-certified — a genuine third-party trust signal many compounded startups lack
• Offers a real brand-name Wegovy/Zepbound pathway alongside compounded tirzepatide, uncommon for a low-cost compounder
• Transparent compounded pricing from $199/month tirzepatide (compounded semaglutide from $149/month)
• Low-friction signup — often no labs and no separate video visit required

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• No named medical director, and the low-friction model (often no labs or visit) means thinner clinical oversight
• The two pharmacies it names — Foothills and Promise — are disclosed only in the Terms and the HIPAA notice, and neither is classified as 503A or 503B anywhere on the site
• Injectable only — no oral tirzepatide pathway
• State availability is quiz-gated rather than published, and $199/month is above the cheapest flat compounders
• FDA issued the company a warning letter in September 2025 — read it on FDA's own site

In its favor

• Ships a body analyzer with the medication at no separate charge and reads fat mass and lean muscle every week, so the dose is tuned against body composition rather than scale weight — a direct answer to the lean-mass loss that follows tirzepatide
• Blends vitamin B12 and glycine into the tirzepatide protocol and states what each is for rather than selling them separately
• Billed monthly with no minimum term, where much of this market asks for a three- or six-month prepay
• Publishes its own average result beside its headline: a footnote states the headline figure is the top quartile of 1,185 users and that average loss was 13 pounds
• Prints the compounded-medication and thyroid C-cell tumour warnings on the checkout itself rather than in a linked page

Against it

• It is a microdose protocol — smaller-than-standard doses — so its price cannot be compared with a standard-dose program at the same figure; the weight-loss results this category advertises come from 5–15 mg doses
• The figure is a floor: the terms charge a non-refundable clinical consultation fee at enrollment and at every refill, never state its size, and reserve the right to charge more for certain dosages or formulations
• The marketing promises 180 days money back; the contract offers 90 days, pays out only if you achieved no measurable weight loss at all, excludes that consultation fee, and disqualifies anyone who has used a GLP-1 before
• Names no pharmacy and states no 503A or 503B classification anywhere
• Publishes no milligram figure, including at the checkout, which says only that the provider sets the final dose
• Not available in Alabama, Louisiana or Mississippi

In its favor

• LegitScript-certified (#50087439) — a genuine third-party trust signal most compounded providers lack
• Physician-supervised, with a licensed U.S. 503A compounding pharmacy
• Offers tirzepatide, semaglutide, and a rare oral GLP tablet alongside injectable
• Transparent monthly pricing with no insurance required

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Several tiers are company-stated and could not be independently verified on a live public page
• Brand tiers are an expensive pass-through (~$1,299)
• Number of states served is not published

In its favor

• Flat $219/mo tirzepatide regardless of dose escalation
• Tirzepatide compounded with B12 to reduce nausea
• Flat plan includes unlimited virtual provider visits
• Fully online intake-to-delivery process
• Compounded from licensed US pharmacies

Against it

• Weight loss is secondary to core TRT business
• Specific pharmacy partner and 503A status not disclosed
• Compounded only; not FDA-approved formulations
• State licensing list not published

In its favor

• Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
• Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
• LegitScript Certified (seal ID 49690100 in footer)
• Flat per-tier pricing — no dose-escalation surcharge
• Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide

Against it

• Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
• Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
• Lowest advertised prices require 12-month commitment with no partial refunds
• No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
• Founder names and funding undisclosed on site